Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
Int J Gynecol Pathol. 2012 Sep;31(5):416-22. doi: 10.1097/PGP.0b013e31824cbeb4.
There is mounting evidence that serous tubal intraepithelial carcinoma (STIC) may be the immediate precursor of ovarian high-grade serous carcinoma (HGSC) but the criteria for its diagnosis are not well established as highlighted in a recent study showing that interobserver reproducibility, even among expert gynecologic pathologists, was moderate at best. Given the clinical significance of a diagnosis of STIC in a patient who has no other evidence of ovarian carcinoma, this is a serious issue that we felt needed to be addressed. Although it is not clear, at this time, whether such a patient should or should not be treated, the importance of an accurate and reproducible diagnosis of precursors of ovarian carcinoma cannot be underestimated. We hypothesized that an elevated Ki-67 labeling index may aid the diagnosis of STIC. Accordingly, we compared the Ki-67 index of STIC and HGSC to normal fallopian tube epithelium (FTE) in the same patients and to a control group of patients without carcinoma, matched for age. A total of 41 STICs were analyzed, of which 35 were associated with a concurrent HGSC. In FTE, immunoreactivity for Ki-67 was restricted to a few scattered cells (mean 2.0%). No statistically significant difference was found between patients with and without HGSC (P>0.05). However, both STICs and HGSC had significantly higher Ki-67 indices than normal FTE (P<0.0001). STICs uniformly had an elevated Ki-67 labeling index that ranged from 11.7% to 71.1% (average 35.6%). There was no correlation of the Ki-67 labeling index in the STICs and the associated HGSC, as the labeling index was lower in STIC in 18/35 (51.4%) whereas it was higher in 17/35 (48.6%) (P=0.86). In conclusion, the findings in this study indicate that compared with FTE, STICs have a significantly higher Ki-67 index similar to HGSC. Accordingly, the Ki-67 index can aid the diagnosis of intraepithelial tubal proliferations suspicious for STIC. Therefore, we propose that a Ki-67 index of 10% is a useful diagnostic tool to distinguish STICs from normal FTE.
越来越多的证据表明,输卵管上皮内浆液性癌(STIC)可能是卵巢高级别浆液性癌(HGSC)的直接前体,但由于最近的一项研究表明,即使在专家级妇科病理学家中,其诊断标准也没有得到很好的建立,因此其诊断标准仍未得到很好的建立。鉴于 STIC 诊断对没有其他卵巢癌证据的患者的临床意义,这是一个严重的问题,我们认为需要解决。尽管目前尚不清楚此类患者是否应该治疗,但对卵巢癌前体的准确和可重复诊断的重要性不容忽视。我们假设升高的 Ki-67 标记指数可能有助于 STIC 的诊断。因此,我们比较了同一患者的 STIC 和 HGSC 与正常输卵管上皮(FTE)以及与年龄匹配的无癌患者的对照组的 Ki-67 指数。共分析了 41 例 STIC,其中 35 例与同时发生的 HGSC 相关。在 FTE 中,Ki-67 的免疫反应性仅限于少数散在的细胞(平均值 2.0%)。在有或没有 HGSC 的患者之间未发现统计学上的显著差异(P>0.05)。然而,STIC 和 HGSC 的 Ki-67 指数均显著高于正常 FTE(P<0.0001)。STIC 普遍具有升高的 Ki-67 标记指数,范围为 11.7%至 71.1%(平均值 35.6%)。在 35 例 STIC 中,有 18 例(51.4%)的 STIC 中 Ki-67 标记指数较低,而有 17 例(48.6%)的 STIC 中 Ki-67 标记指数较高,两者之间无相关性(P=0.86)。总之,本研究的结果表明,与 FTE 相比,STIC 的 Ki-67 指数明显更高,与 HGSC 相似。因此,Ki-67 指数可有助于诊断可疑为 STIC 的上皮内输卵管增生。因此,我们建议 Ki-67 指数为 10%是区分 STIC 和正常 FTE 的有用诊断工具。